HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruth E Ley Selected Research

Hyperlipidemias (Hyperlipidemia)

4/2010Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ruth E Ley Research Topics

Disease

9Inflammation (Inflammations)
12/2019 - 03/2012
6Colitis
12/2019 - 03/2012
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2015 - 04/2010
2Insulin Resistance
01/2020 - 04/2010
2Obesity
12/2019 - 01/2015
2Hypertension (High Blood Pressure)
01/2017 - 04/2010
1Cardiovascular Diseases (Cardiovascular Disease)
02/2021
1Lactose Intolerance (Intolerance, Lactose)
11/2017
1Body Weight (Weight, Body)
01/2017
1Type 2 Diabetes Mellitus (MODY)
01/2017
1Metabolic Diseases (Metabolic Disease)
09/2016
1Peptic Ulcer (Peptic Ulcers)
05/2016
1Gastroesophageal Reflux (GERD)
05/2016
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2015
1Splenomegaly
12/2014
1Dysbiosis
07/2014
1Caliciviridae Infections
08/2012
1Atherosclerosis
03/2011
1Atherosclerotic Plaque (Atheroma)
03/2011
1Necrotizing Enterocolitis
01/2011
1Hyperphagia (Overeating)
04/2010
1Hyperlipidemias (Hyperlipidemia)
04/2010
1Infections
04/2010
1Autoimmune Diseases (Autoimmune Disease)
10/2008
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2008
1Weight Loss (Weight Reduction)
12/2006

Drug/Important Bio-Agent (IBA)

5FlagellinIBA
12/2019 - 08/2012
5Toll-Like Receptor 5IBA
12/2014 - 04/2010
2Interleukin-10 (Interleukin 10)IBA
12/2019 - 03/2012
2Insulin (Novolin)FDA Link
01/2017 - 10/2008
2LipopolysaccharidesIBA
12/2014 - 07/2014
1trimethylamineIBA
02/2021
1CeramidesIBA
01/2020
1SphingolipidsIBA
01/2020
1Immunoglobulin A (IgA)IBA
12/2019
1AntibodiesIBA
12/2019
1VaccinesIBA
12/2019
1LactaseIBA
11/2017
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2017
1Bile Acids and Salts (Bile Acids)IBA
01/2017
1salicylhydroxamic acid (SHAM)IBA
01/2017
1Glucose (Dextrose)FDA LinkGeneric
01/2017
1Proton Pump InhibitorsIBA
05/2016
1Emulsifying AgentsIBA
01/2015
1Detergents (Detergent)IBA
01/2015
1Carboxymethylcellulose Sodium (Polycell)FDA Link
01/2015
1Anti-Bacterial Agents (Antibiotics)IBA
12/2014
1Toll-Like Receptors (Toll-Like Receptor)IBA
12/2014
1Interleukin-22 (IL-22)IBA
12/2014
1Lipocalin-2IBA
12/2014
1InflammasomesIBA
07/2014
1Proteins (Proteins, Gene)FDA Link
11/2013
1Antiviral Agents (Antivirals)IBA
08/2012
1LeptinIBA
04/2012
1Interleukin-10 ReceptorsIBA
03/2012
1CytokinesIBA
03/2012
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
03/2012
1Toll-Like Receptor 4IBA
03/2012
116S Ribosomal RNAIBA
03/2011
1Bacterial DNAIBA
03/2011
1DNA (Deoxyribonucleic Acid)IBA
03/2011
1Fatty Acids (Saturated Fatty Acids)IBA
01/2011

Therapy/Procedure

2Therapeutics
02/2021 - 09/2016
2Gastrectomy
01/2017 - 01/2017
1Bariatric Surgery
01/2017
1Drug Therapy (Chemotherapy)
07/2014
1Radiotherapy
07/2014
1Caloric Restriction
12/2006